Akhil Rajendra
E Borges Road, 400 012
Mumbai, MH, India
Mumbai, MH, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Clinical development of a CDK8/19 kinase inhibitor for acute myeloid leukemia.
Journal: Expert opinion on investigational drugs
Published: April 03, 2026
Paradoxical reactions in patients with tuberculous lymphadenitis: A pilot immunopathogenic study.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: December 12, 2025
What is the Prognostic Relevance of Responses Less Than a CR to Initial AML Treatment?
Journal: Clinical lymphoma, myeloma & leukemia
Published: September 18, 2025
Who truly benefits from gilteritinib combinations in FLT3-mutated relapsed-refractory(R/R) AML: a Canadian single center analysis.
Journal: Blood cancer journal
Published: April 21, 2025
Outcomes and prognostic factors in patients with Burkitt lymphoma/leukemia in adolescents and adults: an experience from hematology cancer consortium.
Journal: Blood cancer journal
Published: September 24, 2024
Advances in Stem Cell Transplantation for Myelofibrosis.
Journal: Current hematologic malignancy reports
Published: August 05, 2024
Correction: Epidemiological Trend of Esophageal Cancer at a Tertiary Cancer Center in Mumbai, India, over the Past 15 Years.
Journal: Journal of gastrointestinal cancer
Published: July 17, 2024
Treatment challenges and outcomes of older patients with acute myeloid leukemia from India.
Journal: Annals of hematology
Published: March 11, 2024
Impact of the COVID-19 pandemic on treatment of patients with acute myeloid leukaemia in India.
Journal: British journal of haematology
Published: January 29, 2024
Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL).
Journal: Leukemia & lymphoma
Published: August 21, 2023
Efficacy and Safety of Low-Dose Nivolumab in Treatment of Advanced Solid Tumors: A Retrospective Audit from Resource-Constrained Settings.
Journal: South Asian journal of cancer
Published: August 01, 2023
A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome.
Journal: Leukemia & lymphoma
Published: March 09, 2023
Last Updated: 09/26/2026